TABLE 1.
Baseline Characteristics of Study Participants
| Participant Characteristics | Group A: Computerized CR (n = 55) | Group B: Exercises at Home (n = 56) | Group C: Phone Call (n = 56) |
|---|---|---|---|
| Age, y, median (range) | 51.7 (35‐72) | 50.9 (28‐78) | 50.7 (24‐77) |
| Sex, n (%) | |||
| Women | 53 (96.4) | 53 (94.6) | 54 (96.4) |
| Men | 2 (3.6) | 3 (5.4) | 2 (3.6) |
| Education level, n (%) | |||
| Primary school | 4 (7.3) | 3 (5.4) | 2 (3.6) |
| Middle school | 8 (14.55) | 9 (16.1) | 10 (17.8) |
| High school | 8 (14.55) | 11 (19.6) | 9 (16.1) |
| University | 28 (50.9) | 25 (44.6) | 31 (55.4) |
| Unknown | 7 (12.7) | 8 (14.3) | 4 (7.1) |
| Cancer variables | |||
| Cancer type, n (%) | |||
| Breast | 47 (85.5) | 48 (85.7) | 45 (80.3) |
| Digestive | 4 (7.3) | 2 (3.6) | 1 (1.8) |
| Hematologic | 2 (3.6) | 3 (5.35) | 2 (3.6) |
| Urologic/Gynecologic | 1 (1.8) | 3 (5.35) | 7 (12.5) |
| Other | 1 (1.8) | 0 | 1 (1.8) |
| Presence of metastases, n (%) | 7 (12.7) | 2 (3.6) | 6 (10.7) |
| Time since chemotherapy completion, mo, median (range) | 11.7 (7.7‐18.3) | 9.5 (6.2‐20.8) | 10.5 (5.7‐19.3) |
| Prior anticancer therapies | |||
| Surgery, n (%) | 50 (90.9) | 51 (91.1) | 51(91.1) |
| Radiotherapy, n (%) | 44 (80.0) | 43 (76.8) | 45 (80.3) |
| Hormone therapy, n (%) | 29 (51.8) | 37 (66.1) | 32 (57.1) |
| Patient‐reported outcomes | |||
| FACT‐Cog, mean (SD) | |||
| PCI | 33.2 (13.2) | 35.4 (15.6) | 34.1 (13.6) |
| PCA | 11.0 (5.0) | 12.2 (4.5) | 11.2 (4.3) |
| FACT impact on QOL | 6.0 (4.0) | 6.8 (3.6) | 5.9 (3.4) |
| FACT comments from others | 11.5 (4.3) | 12.3 (3.5) | 11.9 (3.9) |
| Depression CES‐D, mean (SD) | 21.7 (9.9) | 20.4 (9.7) | 22.4 (9.1) |
| Anxiety STAI‐Trait, mean (SD) | 45.6 (12.1) | 45.4 (11.5) | 47.5 (10.4) |
| Fatigue FACT‐An, mean (SD) | 50.2 (12.2) | 50.1 (12.4) | 46.7 (13.5) |
| QOL FACT‐G, mean (SD) | 71.2 (15.2) | 70.3 (15.4) | 67.4 (14.8) |
Abbreviations: CES‐D, Center for Epidemiologic Studies Depression Scale; CR, cognitive rehabilitation; FACT‐An, Functional Assessment of Cancer Therapy–Anemia; FACT‐Cog, Functional Assessment of Cancer Therapy–Cognitive Function; FACT‐G, Functional Assessment of Cancer Therapy–General; PCA, perceived cognitive abilities; PCI, perceived cognitive impairments; QOL, quality of life; STAI‐Trait, Spielberger State‐Trait Anxiety Inventory.